Article Details

Adding Venetoclax to Decitabine-Cedazuridine Improves Response in MDS Subgroups

Retrieved on: 2025-04-25 22:03:48

Tags for this article:

Click the tags to see associated articles and topics

Adding Venetoclax to Decitabine-Cedazuridine Improves Response in MDS Subgroups. View article details on hiswai:

Excerpt

Adding venetoclax to an HMA is the standard of care for patients with AML who cannot receive intensive chemotherapy. “AML shares several clinical and ...

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo